Anurag Kumar Singh

About

I am Dr. Anurag Kumar Singh, currently working as an Institute Postdoctoral Fellow (I-PDF) in the Department of Biochemistry, Institute of Science, Banaras Hindu University (BHU), Varanasi, India, since May 20, 2026. Previously, I worked as an ICMR-Research Associate at IIT (BHU), Varanasi, from November 3, 2022, to November 2, 2025, focusing on chronic pain management and opioid-based therapeutics. Earlier, I served as a Postdoctoral Research Associate at Alabama State University, USA, from April 4, 2022, to October 3, 2022, with research experience in biomedical and cancer biology.

Employment

• Banaras Hindu University Institute Postdoctoral Fellow (I-PDF)
  2026 - Present
• Indian Institute of Technology BHU ICMR-Research Associate (ICMR-RA)
  2022 - 2025
• Alabama State University Postdoctoral Research Associate
  2022 - 2022

Education

• Banaras Hindu University PhD (Doctor of Philosophy)
  2017 - 2021
• Central University of Rajasthan Master of Pharmacy
  2014 - 2016
• Indian Law Institute Certificate Course in IPR
  2013 - 2014
• Uttar Pradesh Technical University Bachelor of Pharmacy
  2008 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (76)

• Electrospun Hyaluronic Acid/Polyvinyl Alcohol Nanofibers Encapsulating Defactinib as Bioactive Dressings for Burn Wound Therapy
  ACS Applied Bio Materials 2026 1 citation DOI: 10.1021/acsabm.5c02361
  +Save
• Folic acid-functionalized PLGA-cystamine nanoparticles for glutathione-responsive capecitabine delivery in pancreatic cancer: in vitro and in vivo evaluation
  Journal of Drug Targeting 2026 0 citations DOI: 10.1080/1061186x.2026.2716722
  +Save
• Porous silicon-based drug delivery carriers in cancer management
  Drug Delivery and Biomedical Applications of Porous Silicon-Based Nanocarriers 2026 0 citations DOI: 10.1016/b978-0-443-24802-3.00006-8
  +Save
• Porous silicon nanoparticles in codelivery of drugs for improved cellular uptake and targeted drug delivery
  Drug Delivery and Biomedical Applications of Porous Silicon-Based Nanocarriers 2026 0 citations DOI: 10.1016/b978-0-443-24802-3.00021-4
  +Save
• Porous silicon nanocarriers for the management of neurodegenerative disorders
  Drug Delivery and Biomedical Applications of Porous Silicon-Based Nanocarriers 2026 0 citations DOI: 10.1016/b978-0-443-24802-3.00009-3
  +Save
• Nanotheranostics in Metabolic Syndrome
  Springer Nature Singapore 2026 1 citation DOI: 10.1007/978-981-95-3746-4
  +Save
• Nano-Bio-Medicine for Gastrointestinal Diseases
  2026 0 citations DOI: 10.1016/c2023-0-50755-4
  +Save
• Introduction: NanoBioMedicine and its promise in gastrointestinal diseases
  Nano-Bio-Medicine for Gastrointestinal Diseases 2026 0 citations DOI: 10.1016/b978-0-443-34039-0.00007-x
  +Save
• Introduction to Nanotheranostics and Metabolic Syndrome
  Nanotheranostics in Metabolic Syndrome 2026 0 citations DOI: 10.1007/978-981-95-3746-4_1
  +Save
• Introduction to Antimicrobial Resistance (AMR)
  Harnessing Nanozymes to Combat Antimicrobial Resistance 2026 0 citations DOI: 10.1007/978-3-032-16540-4_1
  +Save